XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 5,966 $ 761,617  
Adjustments to reconcile net (loss) income to net cash flows from operating activities:      
Note receivable revaluation (334,400) 0  
Other income from W-1 Warrant mark-to-market 252,000 0  
Stock based compensation 81,746 0  
Amortization and depreciation 20,715 0  
(Increase) decrease in:      
Accounts receivable (28,221) (138,606)  
Prepaids (10,899) 0  
Other current assets 22,517 4,567  
Deferred tax assets, net 32,233 0  
Increase (decrease) in:      
Accounts payable (59,097) 0  
Accrued compensation 378,283 0  
Accrued expenses 118,480 321,717  
Deferred revenue 11,188 0  
Other current liabilities (140) 0  
Net cash provided by operating activities 490,371 949,295  
Cash flows from investing activities:      
(Increase) decrease in investments (547,667) 2,849  
Investment in private company (955,266) 0  
Net cash (used in) provided by investing activities (1,502,933) 2,849  
Cash flows from financing activities:      
Decrease in due from affiliate 123,823 0  
Decrease in due to affiliate 0 (1,582,396)  
Net cash provided by (used in) financing activities 123,823 (1,582,396)  
Net decrease in cash (888,739) (630,252)  
Cash and cash equivalents at beginning of the period - January 1 10,690,398 1,272,924 $ 1,272,924
Cash and cash equivalents at end of the period - March 31 $ 9,801,659 $ 642,672 $ 10,690,398